We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.51 | 34.2281879195 | 1.49 | 2.18 | 1.49 | 15010 | 1.73471494 | CS |
4 | 0.43 | 27.3885350318 | 1.57 | 2.18 | 1.45 | 18640 | 1.72656418 | CS |
12 | -0.95 | -32.2033898305 | 2.95 | 3.25 | 1.16 | 38141 | 2.28254849 | CS |
26 | -1 | -33.3333333333 | 3 | 3.25 | 1.16 | 66516 | 2.21426905 | CS |
52 | -1 | -33.3333333333 | 3 | 3.25 | 1.16 | 66516 | 2.21426905 | CS |
156 | -1 | -33.3333333333 | 3 | 3.25 | 1.16 | 66516 | 2.21426905 | CS |
260 | -1 | -33.3333333333 | 3 | 3.25 | 1.16 | 66516 | 2.21426905 | CS |
Symbol | Price | Vol. |
---|---|---|
SGNSigning Day Sports Inc | US$ 4.3099 (122.16%) | 97.15M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 25.68 (1.22%) | 94.14M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3.36 (8.04%) | 76.89M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2.51 (4.80%) | 75.33M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5.825 (1.48%) | 70.15M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions